Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Ahmed Amine Ben KhlilImen ZamaliDorra BelloumiMariem GdouraGhassen KharroubiSoumaya MarzoukiRym DachraouiInsaf Ben YaicheSoumaya BchiriWalid HamdiManel GharbiAhlem Ben HmidSamar SamoudYousr GalaiLamia TorjmaneSaloua LadebJihene BettaiebHenda TrikiNour Ben AbdeljelilTarek Ben OthmanMelika Ben Ahmed

Published in: Vaccines (2024)

anti-SARS-CoV-2 vaccination is well tolerated in ASCT patients, inducing robust humoral and cellular responses. Further exploration is warranted to understand the impact of a mixed cytokine profile in ASCT patients.

Keyphrases

end stage renal disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
hematopoietic stem cell
bone marrow
low dose
coronavirus disease
patient reported